JP2022544683A5 - - Google Patents
Info
- Publication number
- JP2022544683A5 JP2022544683A5 JP2022509648A JP2022509648A JP2022544683A5 JP 2022544683 A5 JP2022544683 A5 JP 2022544683A5 JP 2022509648 A JP2022509648 A JP 2022509648A JP 2022509648 A JP2022509648 A JP 2022509648A JP 2022544683 A5 JP2022544683 A5 JP 2022544683A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025152149A JP2026009903A (ja) | 2019-08-16 | 2025-09-12 | 新規な抗ｔｃｒデルタ可変１抗体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1911799.3A GB201911799D0 (en) | 2019-08-16 | 2019-08-16 | Novel Antibodies |
| GB1911799.3 | 2019-08-16 | ||
| GB2010760.3 | 2020-07-13 | ||
| GBGB2010760.3A GB202010760D0 (en) | 2020-07-13 | 2020-07-13 | Novel antibodies |
| PCT/GB2020/051955 WO2021032960A1 (en) | 2019-08-16 | 2020-08-14 | Novel anti-tcr delta variable 1 antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025152149A Division JP2026009903A (ja) | 2019-08-16 | 2025-09-12 | 新規な抗ｔｃｒデルタ可変１抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544683A JP2022544683A (ja) | 2022-10-20 |
| JPWO2021032960A5 JPWO2021032960A5 (https=) | 2023-08-21 |
| JP2022544683A5 true JP2022544683A5 (https=) | 2023-08-21 |
Family
ID=72148174
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509648A Pending JP2022544683A (ja) | 2019-08-16 | 2020-08-14 | 新規な抗ｔｃｒデルタ可変１抗体 |
| JP2022509647A Pending JP2022545196A (ja) | 2019-08-16 | 2020-08-14 | 抗ｔｃｒデルタ可変１抗体の治療的使用 |
| JP2025113769A Pending JP2025160218A (ja) | 2019-08-16 | 2025-07-04 | 抗ｔｃｒデルタ可変１抗体の治療的使用 |
| JP2025152149A Pending JP2026009903A (ja) | 2019-08-16 | 2025-09-12 | 新規な抗ｔｃｒデルタ可変１抗体 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509647A Pending JP2022545196A (ja) | 2019-08-16 | 2020-08-14 | 抗ｔｃｒデルタ可変１抗体の治療的使用 |
| JP2025113769A Pending JP2025160218A (ja) | 2019-08-16 | 2025-07-04 | 抗ｔｃｒデルタ可変１抗体の治療的使用 |
| JP2025152149A Pending JP2026009903A (ja) | 2019-08-16 | 2025-09-12 | 新規な抗ｔｃｒデルタ可変１抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220403025A1 (https=) |
| EP (2) | EP4013504A1 (https=) |
| JP (4) | JP2022544683A (https=) |
| KR (2) | KR20220084020A (https=) |
| CN (2) | CN114222585A (https=) |
| AU (2) | AU2020332878A1 (https=) |
| BR (1) | BR112022002837A2 (https=) |
| CA (2) | CA3145523A1 (https=) |
| CL (2) | CL2022000368A1 (https=) |
| CO (1) | CO2022002001A2 (https=) |
| IL (1) | IL290537A (https=) |
| MX (1) | MX2022002075A (https=) |
| WO (2) | WO2021032963A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107531787B (zh) | 2015-01-27 | 2022-01-18 | 拉法医疗有限公司 | 靶向cd1d的单域抗体 |
| US10519236B2 (en) | 2018-01-23 | 2019-12-31 | New York University | Antibodies specific to delta 1 chain of T cell receptor |
| GB201811404D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | Anti-CD137 Antibodies |
| WO2020060406A1 (en) | 2018-09-19 | 2020-03-26 | Lava Therapeutics B.V. | Novel bispecific antibodies for use in the treatment of hematological malignancies |
| US12084500B2 (en) | 2019-01-23 | 2024-09-10 | New York University | Antibodies specific to delta 1 chain of T cell receptor |
| CA3145523A1 (en) * | 2019-08-16 | 2021-02-25 | GammaDelta Therapeutics Limited | Therapeutic uses of anti-tcr delta variable 1 antibodies |
| GB202002581D0 (en) * | 2020-02-24 | 2020-04-08 | Gammadelta Therapeutics Ltd | Novel antibodies |
| CN116323667A (zh) | 2020-07-08 | 2023-06-23 | 拉法医疗股份有限公司 | 结合PSMA和γ-δT细胞受体的抗体 |
| LT4269444T (lt) * | 2020-08-14 | 2024-09-25 | GammaDelta Therapeutics Limited | Daugiaspecifiniai anti-tcr kintamos delta 1 antikūnai |
| TW202246338A (zh) | 2021-02-17 | 2022-12-01 | 英商適應生物治療有限公司 | 抗ＴＣＲδ可變1抗體 |
| AU2022222299A1 (en) | 2021-02-17 | 2023-09-07 | F-Star Therapeutics Limited | Multispecific anti-tcr delta variable 1 antibodies |
| EP4147716A1 (en) * | 2021-09-10 | 2023-03-15 | Samatva Research Corporation | Anti-virus moiety immobilised in a matrix |
| CA3208653A1 (en) | 2022-02-17 | 2022-08-25 | Mihriban Tuna | Multispecific anti-tcr delta variable 1 antibodies |
| WO2024200573A1 (en) | 2023-03-27 | 2024-10-03 | LAVA Therapeutics N.V. | Nectin-4 binding agents and methods of use |
| WO2025012118A2 (en) | 2023-07-07 | 2025-01-16 | LAVA Therapeutics N.V. | 5t4 binding agents and methods of use |
| CN121752599A (zh) * | 2023-08-31 | 2026-03-27 | 南京传奇生物科技有限公司 | 抗γδTCR抗体及其用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100591761C (zh) * | 2004-08-19 | 2010-02-24 | 加的夫大学学院咨询有限公司 | 呈递抗原的人γδT细胞的制备和在免疫治疗中的用途 |
| EP2546268A1 (en) | 2011-07-13 | 2013-01-16 | F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. | Internalising immunoglobulin |
| CN102295702B (zh) * | 2011-08-26 | 2014-01-29 | 中国科学院微生物研究所 | 一种针对t细胞受体可变区特异性单抗的制备方法 |
| GB201506423D0 (en) * | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| WO2016081518A2 (en) * | 2014-11-17 | 2016-05-26 | Adicet Bio, Inc. | Engineered gamma delta t-cells |
| AU2016274633B2 (en) | 2015-06-09 | 2022-04-21 | Gammadelta Therapeutics Ltd | Methods for the production of TCR gamma delta+ T cells |
| EP4148124A1 (en) | 2015-10-30 | 2023-03-15 | Cancer Research Technology Limited | Expansion of non-haematopoietic tissue-resident gamma delta t cells and uses of these cells |
| CN109789201B (zh) * | 2016-04-15 | 2023-06-16 | 伊穆奈克斯特股份有限公司 | 抗人vista抗体及其用途 |
| EP3454870A4 (en) * | 2016-05-12 | 2020-03-04 | Adicet Bio Inc. | METHOD FOR SELECTIVE EXPANSION OF GAMMA DELTA T CELL POPULATIONS AND COMPOSITIONS THEREOF |
| GB201612520D0 (en) | 2016-07-19 | 2016-08-31 | F-Star Beta Ltd | Binding molecules |
| US10546518B2 (en) | 2017-05-15 | 2020-01-28 | Google Llc | Near-eye display with extended effective eyebox via eye tracking |
| US10519236B2 (en) * | 2018-01-23 | 2019-12-31 | New York University | Antibodies specific to delta 1 chain of T cell receptor |
| GB201818243D0 (en) | 2018-11-08 | 2018-12-26 | Gammadelta Therapeutics Ltd | Methods for isolating and expanding cells |
| EP3965818A4 (en) * | 2019-05-08 | 2023-05-31 | Janssen Biotech, Inc. | MATERIALS AND METHODS FOR MODULATION OF T-CELL-MEDIATED IMMUNITY |
| CA3145523A1 (en) * | 2019-08-16 | 2021-02-25 | GammaDelta Therapeutics Limited | Therapeutic uses of anti-tcr delta variable 1 antibodies |
-
2020
- 2020-08-14 CA CA3145523A patent/CA3145523A1/en active Pending
- 2020-08-14 AU AU2020332878A patent/AU2020332878A1/en active Pending
- 2020-08-14 WO PCT/GB2020/051959 patent/WO2021032963A1/en not_active Ceased
- 2020-08-14 JP JP2022509648A patent/JP2022544683A/ja active Pending
- 2020-08-14 US US17/633,439 patent/US20220403025A1/en active Pending
- 2020-08-14 EP EP20758305.5A patent/EP4013504A1/en active Pending
- 2020-08-14 CN CN202080057206.1A patent/CN114222585A/zh active Pending
- 2020-08-14 KR KR1020227008860A patent/KR20220084020A/ko active Pending
- 2020-08-14 WO PCT/GB2020/051955 patent/WO2021032960A1/en not_active Ceased
- 2020-08-14 JP JP2022509647A patent/JP2022545196A/ja active Pending
- 2020-08-14 AU AU2020333406A patent/AU2020333406A1/en active Pending
- 2020-08-14 KR KR1020227008859A patent/KR20220084019A/ko active Pending
- 2020-08-14 MX MX2022002075A patent/MX2022002075A/es unknown
- 2020-08-14 CA CA3145517A patent/CA3145517A1/en active Pending
- 2020-08-14 EP EP20758308.9A patent/EP4013505A1/en active Pending
- 2020-08-14 BR BR112022002837A patent/BR112022002837A2/pt unknown
- 2020-08-14 CN CN202080065477.1A patent/CN114514245A/zh active Pending
-
2022
- 2022-02-10 IL IL290537A patent/IL290537A/en unknown
- 2022-02-15 CL CL2022000368A patent/CL2022000368A1/es unknown
- 2022-02-24 CO CONC2022/0002001A patent/CO2022002001A2/es unknown
-
2024
- 2024-07-25 CL CL2024002250A patent/CL2024002250A1/es unknown
-
2025
- 2025-07-04 JP JP2025113769A patent/JP2025160218A/ja active Pending
- 2025-09-12 JP JP2025152149A patent/JP2026009903A/ja active Pending